30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Sergio Traversa

Track

Insider profile

Currently holds a position at Relmada Therapeutics Inc

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 30% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
19 74% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Executive Officer, Director Relmada Therapeutics Inc July 29, 2019 -
Chief Executive Officer, Interim Chief Financial Officer, Principal Financial and Accounting Officer, Director Relmada Therapeutics Inc Feb. 16, 2017 - July 29, 2019
Independent Director Actinium Pharmaceuticals Inc Aug. 1, 2012 - June 6, 2017
Chief Executive Officer, Director Relmada Therapeutics Inc May 20, 2014 - Feb. 16, 2017
Sergio Traversa's trades of Relmada Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-16 2025-12-15
B Purchase
90,407 +3.6%
315.92
US$4,220,053 		90,407 +3.6% 315.92 US$4,220,053
2025-11-06 2025-11-05
B Purchase
88,563 +44.1%
458.67
US$2,958,867 		88,563 +44.1% 458.67 US$2,958,867
2025-08-28 2025-08-28
B Purchase
85,034 -25.9%
79.61
US$2,963,408 		85,034 -25.9% 79.61 US$2,963,408
2025-08-28 2025-08-27
B Purchase
129,455 +15.9%
0.67
US$86,735 		129,455 +15.9% 0.67 US$86,735
2025-08-28 2025-08-26
B Purchase
80,545 +11.0%
0.62
US$49,938 		80,545 +11.0% 0.62 US$49,938
2025-05-20 2025-05-20
B Purchase
147,686 +25.2%
0.56
US$82,246 		147,686 +25.2% 0.56 US$82,246
2025-05-20 2025-05-19
B Purchase
30,000 +5.4%
0.50
US$14,994 		30,000 +5.4% 0.50 US$14,994
2025-05-20 2025-05-16
B Purchase
172,314 +44.9%
0.45
US$77,472 		172,314 +44.9% 0.45 US$77,472
2024-09-11 2024-09-11
B Purchase
51,407 +15.5%
2.99
US$153,707 		51,407 +15.5% 2.99 US$153,707
2024-09-11 2024-09-10
B Purchase
33,014 +11.0%
2.75
US$90,788 		33,014 +11.0% 2.75 US$90,788
2024-09-11 2024-09-09
B Purchase
55,579 +22.8%
2.71
US$150,619 		55,579 +22.8% 2.71 US$150,619
2024-01-31 2024-01-31
B Purchase
27,460 +12.7%
4.00
US$109,752 		27,460 +12.7% 4.00 US$109,752
2024-01-31 2024-01-30
B Purchase
40,999 +23.4%
3.90
US$159,949 		40,999 +23.4% 3.90 US$159,949
2024-01-31 2024-01-29
B Purchase
31,541 +21.9%
3.71
US$117,036 		31,541 +21.9% 3.71 US$117,036
2022-12-12 2022-12-08
B Purchase
55,250 +62.2%
2.10
US$115,804 		55,250 +62.2% 2.10 US$115,804
2022-07-05 2022-07-01
S Sale
4,068 -4.4%
18.32
US$74,526 		4,068 -4.4% 18.32 US$74,526
2022-07-05 2022-07-01
S Sale
8,848 -8.7%
18.45
US$163,246 		8,848 -8.7% 18.45 US$163,246
2022-07-05 2022-07-01
S Sale
839 -0.8%
18.48
US$15,505 		839 -0.8% 18.48 US$15,505
2022-07-05 2022-06-30
S Sale
10,698 -10.8%
19.01
US$203,369 		10,698 -10.8% 19.01 US$203,369
2022-07-05 2022-06-30
S Sale
5,314 -5.1%
19.37
US$102,932 		5,314 -5.1% 19.37 US$102,932
2021-03-11 2021-03-10
PlS Planned sale
2,983 -3.3%
35.09
US$104,676 		2,983 -3.3% 35.09 US$104,676
2021-03-11 2021-03-09
PlS Planned sale
1,800 -1.9%
36.32
US$65,380 		1,800 -1.9% 36.32 US$65,380
2021-03-11 2021-03-09
PlS Planned sale
5,217 -5.3%
35.42
US$184,789 		5,217 -5.3% 35.42 US$184,789
2021-02-26 2021-02-24
PlS Planned sale
303 -0.3%
35.55
US$10,771 		303 -0.3% 35.55 US$10,771
2021-02-26 2021-02-24
PlS Planned sale
4,860 -5.2%
34.70
US$168,659 		4,860 -5.2% 34.70 US$168,659
2021-02-26 2021-02-24
PlS Planned sale
4,837 -4.9%
33.69
US$162,963 		4,837 -4.9% 33.69 US$162,963
2021-02-16 2021-02-11
PlS Planned sale
1,446 -1.6%
35.43
US$51,238 		1,446 -1.6% 35.43 US$51,238
2021-02-10 2021-02-10
PlS Planned sale
1,930 -2.1%
35.28
US$68,097 		1,930 -2.1% 35.28 US$68,097
2021-02-10 2021-02-09
PlS Planned sale
5,963 -6.2%
35.21
US$209,939 		5,963 -6.2% 35.21 US$209,939
2021-02-10 2021-02-08
PlS Planned sale
3,313 -3.3%
35.03
US$116,049 		3,313 -3.3% 35.03 US$116,049
2021-02-04 2021-02-03
PlS Planned sale
100 -0.1%
35.00
US$3,500 		100 -0.1% 35.00 US$3,500
2021-02-04 2021-02-02
PlS Planned sale
3,178 -3.5%
35.08
US$111,470 		3,178 -3.5% 35.08 US$111,470
2021-01-29 2021-01-27
PlS Planned sale
100 -0.1%
33.43
US$3,343 		100 -0.1% 33.43 US$3,343
2021-01-29 2021-01-27
PlS Planned sale
5,549 -6.8%
32.86
US$182,340 		5,549 -6.8% 32.86 US$182,340
2021-01-29 2021-01-27
PlS Planned sale
4,351 -5.1%
31.77
US$138,231 		4,351 -5.1% 31.77 US$138,231
2021-01-26 2021-01-26
PlS Planned sale
600 -0.8%
35.15
US$21,090 		600 -0.8% 35.15 US$21,090
2021-01-26 2021-01-25
PlS Planned sale
1,300 -1.7%
35.29
US$45,877 		1,300 -1.7% 35.29 US$45,877
2021-01-26 2021-01-22
PlS Planned sale
434 -0.6%
36.15
US$15,689 		434 -0.6% 36.15 US$15,689
2021-01-26 2021-01-22
PlS Planned sale
1,736 -2.2%
35.44
US$61,524 		1,736 -2.2% 35.44 US$61,524